These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12794857)

  • 1. Chemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems.
    Lozovaya N; Miller AD
    Chembiochem; 2003 Jun; 4(6):466-84. PubMed ID: 12794857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential neuroendocrine responses to chronic variable stress in adult Long Evans rats exposed to handling-maternal separation as neonates.
    Ladd CO; Thrivikraman KV; Huot RL; Plotsky PM
    Psychoneuroendocrinology; 2005 Jul; 30(6):520-33. PubMed ID: 15808921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.
    Müller MB; Zimmermann S; Sillaber I; Hagemeyer TP; Deussing JM; Timpl P; Kormann MS; Droste SK; Kühn R; Reul JM; Holsboer F; Wurst W
    Nat Neurosci; 2003 Oct; 6(10):1100-7. PubMed ID: 12973355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression].
    Cubała WJ; Landowski J
    Psychiatr Pol; 2006; 40(3):415-30. PubMed ID: 17037809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease.
    O'Kane M; Murphy EP; Kirby B
    Exp Dermatol; 2006 Mar; 15(3):143-53. PubMed ID: 16480421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine mechanisms of innate states of attenuated responsiveness of the hypothalamo-pituitary adrenal axis to stress.
    Tilbrook AJ; Clarke IJ
    Front Neuroendocrinol; 2006 Sep; 27(3):285-307. PubMed ID: 16930683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limbic and HPA axis function in an animal model of chronic neuropathic pain.
    Ulrich-Lai YM; Xie W; Meij JT; Dolgas CM; Yu L; Herman JP
    Physiol Behav; 2006 Jun; 88(1-2):67-76. PubMed ID: 16647726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing is everything: evidence for a role of corticolimbic endocannabinoids in modulating hypothalamic-pituitary-adrenal axis activity across developmental periods.
    Lee TT; Gorzalka BB
    Neuroscience; 2012 Mar; 204():17-30. PubMed ID: 22015924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress and the female reproductive system.
    Kalantaridou SN; Makrigiannakis A; Zoumakis E; Chrousos GP
    J Reprod Immunol; 2004 Jun; 62(1-2):61-8. PubMed ID: 15288182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress, visceral obesity, and metabolic complications.
    Kyrou I; Chrousos GP; Tsigos C
    Ann N Y Acad Sci; 2006 Nov; 1083():77-110. PubMed ID: 17148735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
    Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
    Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity.
    Holsboer F
    Eur Arch Psychiatry Neurol Sci; 1989; 238(5-6):302-22. PubMed ID: 2670576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C; Iyer V; Bhatnagar S
    J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypothalamic-pituitary-adrenal and the hypothalamic- pituitary-gonadal axes interplay.
    Mastorakos G; Pavlatou MG; Mizamtsidi M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():172-81. PubMed ID: 16641855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
    Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
    Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat.
    Rotllant D; Armario A
    Neuroscience; 2005; 130(2):427-34. PubMed ID: 15664699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin releasing hormone and its function in the skin.
    Ziegler CG; Krug AW; Zouboulis CC; Bornstein SR
    Horm Metab Res; 2007 Feb; 39(2):106-9. PubMed ID: 17326006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the brain-gut axis in the pathophysiology of Crohn's disease.
    Stasi C; Orlandelli E
    Dig Dis; 2008; 26(2):156-66. PubMed ID: 18431066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.